You seem to have forgotten that GW Pharmaceuticals is listed on Nasdaq.
MassRoots was rejected by Nasdaq - "Nasdaq determined that listing the company could have been seen as aiding the distribution of an illegal substance, MassRoots said."
GWP has over 40 cannabis related patents - has FDA approval to FastTrack Epidiolex. Plus many more patents in the pipeline.
GWP has some patents that could have a deleterious effect on the Mom and Pop operations like TRTC - actually the entire industry.
Be watching for Greenwich Biosciences, Inc.
But there is a huge difference between GWP and a company selling weed.
Any product that GWP sells is manufactured to the FDA standards - TRTC is selling edibles that of uneven quality - they have no manufacturing requirements that are close to the pharmaceutical industry.